Inside Elamipretide’s CRL: Clinical And Surrogate Evidence Deficiencies, And A Path Forward

 
• By Sue Sutter
  
Behind the curtain
The Pink Sheet looks behind the curtain on Stealth's complete response letter. (Shutterstock)

More from Complete Response Letters

More from United States